Literature DB >> 2589449

Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions.

R J Wapner1, F S Cowchock, S S Shapiro.   

Abstract

In two women with antiphospholipid antibodies and recurrent fetal losses refractory to usual treatments, therapy consisting of aspirin, heparin, and intravenous gamma-globulin infusions was successful. Production of antiphospholipid antibodies was not suppressed. The transient decrease in anticoagulant activity noted in one case was not reproduced in vitro and was probably not physiologically important.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589449     DOI: 10.1016/0002-9378(89)90681-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

Review 1.  Intravenous immunoglobulin therapy in antiphospholipid syndrome.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Immunosuppressive therapy in autoimmune disease--a review.

Authors:  T J Counihan; C Feighery
Journal:  Ir J Med Sci       Date:  1991-07       Impact factor: 1.568

Review 3.  Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options.

Authors:  S Braune; R Siekmann; P Vaith; C H Lücking
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 4.  The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses.

Authors:  A Parke
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 5.  Intravenous immune globulin in recurrent abortion.

Authors:  O Heine; G Mueller-Eckhardt
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  When conventional treatment fails: the role of intravenous immunoglobulin in recurrent pregnancy loss secondary to antiphospholipid syndrome.

Authors:  Jacklyn Chay; Karin Lust; Paul Kubler; Leonie Callaway
Journal:  Obstet Med       Date:  2013-05-03

Review 7.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997

Review 9.  Immune modulation of i.v. immunoglobulin in women with reproductive failure.

Authors:  Ae R Han; Sung K Lee
Journal:  Reprod Med Biol       Date:  2018-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.